7 Followers on Owler

Volastra

is a New York-based clinical-stage biotechnology company that researches and develops novel therapies for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights

Volastra

is a New York-based clinical-stage biotechnology company that researches and develops novel therapies for the treatment of cancer... Read more
Volastra CEO: Charles Hugh-Jones

CEO

Charles Hugh-Jones

CEO Approval Rating

86/100

2019

PrivateIndependent Company

Pharmaceuticals & Biotechnology
Biotechnology

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
Funding
$119.2M

News

Regulatory
Oct 03, 2024
OncLive
FDA Grants Fast Track Status to VLS-1488 for Platinum-Resistant High-Grade Serous Ovarian Cancer
Funding
May 16, 2024
SEC
Volastra received $15M in Equity Funding

Volastra Competitors

1Aura
2Checkmate Pharmaceuticals
3AVEO
4NexImmune
5Juno Therapeutics
6bluebird bio
7Perthera
8Kite Pharma
9Jounce
10Bayer
Unlock 22 + competitors

Trending Companies